In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
"HIV programs have no option but to address TB vigorously to save patient lives, safeguard the massive investment in HIV treatment, and to curb the global TB burden," said Diane V. Havlir, MD, chief of UCSF's HIV/AIDS Division at San Francisco General Hospital's Positive Health Program and lead author of a special communication.
The paper, published in the July 23rd issue of the Journal of the American Medical Association, proposes several strategic activities. These initiatives could be implemented within existing HIV care and treatment programs with support by earmarked resources for HIV/TB in the U.S. funded President's Emergency Plan for AIDS Relief and the Global Fund to fight HIV, TB and Malaria.
One recommended measure is intensified TB case finding. The most effective TB control measure is finding and promptly treating TB, according to the authors. Patients with HIV who are undergoing care should be screened for TB along with members of their household, and the HIV patients who have active TB should be treated for this disease within the HIV program. The authors note that because TB may be the disease that brings an HIV patient into care and there are many more clinics for TB than HIV, HIV patients with active TB often are treated in TB clinics and later referred to an HIV program.
In addition, the authors recommend treating all non TB-infected HIV patients preventively with isoniazid therapy. Another strategy is the provision of antiretroviral therapy to HIV patients earlier, before their immune systems are severely compromised. This measure would also lessen HIV patients' risk of TB infection, they say.
The authors emphasize that TB infection control measures should be implemented in both outpatient and inpatient HIV care facilities so that TB is not transmitted in these settings. TB should be recorded and reported to national TB programs by HIV programs to ensure effective tracking of the TB epidemic, and there should be joint HIV and TB planning, they add.
Source: University of California - San Francisco
Related stories:
Study examines cost-effectiveness of HIV monitoring strategy in countries with limited resources
In a computer-based model evaluating the benefits and costs of three types of HIV disease monitoring strategies, early initiation of antiretroviral therapy and monitoring using the CD4 count, a measure of immune system function, instead of based on symptoms appear to provide health benefits in low- and middle-income countries, according to a report in the September 22 issue of
Archives of Internal Medicine.
Researcher micro-sizes genetics testing
Using new "lab on a chip" technology, James Landers hopes to create a hand-held device that may eventually allow physicians, crime scene investigators, pharmacists, even the general public to quickly and inexpensively conduct DNA tests from almost anywhere, without need for a complex and expensive central laboratory.
As personalized, genomic medicine takes off, four developing countries show the way for others
Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations need to foster the new science at home, says a major new Canadian study published today by Nature Publishing Group.
Researchers evaluate cost-effectiveness of genetic screening to guide initial HIV treatment
A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.
Small numbers of patients with drug-resistant TB may account for high proportion of new infections
Inadequate treatment of antibiotic-resistant tuberculosis (TB) can leave patients highly infectious, and small numbers of such patients may drive transmission of the disease in the very health care facilities intended to treat it, according to research published in
PLoS Medicine.
New study on rural HIV care has economic and health implications
An Indiana University study found that HIV care providers in rural Indiana report significant stigma and discrimination in the rural medical referral system surrounding issues of HIV and substance abuse. Providers felt that these factors impeded their ability to offer quality care to their patients.
Operations research promises continued gains for HIV treatment in resource-limited countries
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.
'Nutraceuticals' could prevent diabetes
People at high risk for developing type 2 diabetes might be able to delay or prevent the disease by taking certain food supplements and making lifestyle changes, according to a new book by Dr. James W. Anderson, an internationally recognized authority on metabolic diseases and weight loss and professor emeritus of medicine and clinical nutrition at the University of Kentucky College of Medicine.